InMode (NASDAQ: INMD) — Company Overview, News & Financial Data
InMode develops RF technology devices for minimally invasive cosmetic and dermatological procedures, enhancing patient outcomes.
InMode
InMode (NASDAQ:INMD) is a health technology company, specialized in developing, manufacturing, and marketing devices that harness novel radio-frequency (RF) technology. These advanced devices are utilized in minimally invasive and non-invasive cosmetic and dermatological procedures, aiming to deliver innovative solutions that improve patient outcomes and enhance quality of life. The company has a diversified project portfolio, focusing on areas such as body contouring, aesthetic surgery, women’s health, and skin treatment. InMode's primary objective is to revolutionize the cosmetic surgery and dermatology sectors by providing safer, effective, and less invasive treatment options to patients worldwide. By leveraging cutting-edge RF technology, InMode seeks to lead transformations within these medical fields, ensuring professionals have access to the latest advancements in medical aesthetic treatments.
Snapshot
Operations
Products and/or services of InMode
- Morpheus8 - A minimally invasive microneedling device combining radiofrequency to remodel collagen, skin, and tissue.
- Evoke - A hands-free facial remodeling platform for the cheeks, neck, and jawline.
- Evolve - A non-invasive technology providing remodeling for the skin, adipose tissue, and muscles.
- Contoura - A body contouring system targeting cellulite and fat reduction while tightening the skin.
- Optimas - A suite of technologies including laser, pulsed light, and radio-frequency for skin treatment and hair removal.
- FormaV & Votiva - Devices for women's health, offering non-invasive treatments for vaginal rejuvenation and blood circulation.
InMode executive team
- Michael KreindelCo-Founder, CTO & Director
- Nava Tal-LaunerChief Information Officer
- Yair MalcaConsultant
- Michael DennisonPresident of North America
- Moshe MizrahyCo-Founder, CEO & Director
- Moshe ItzkovichChief Financial Officer
- Eran KriegerChief Medical Officer
Latest news about InMode
Key financials
Reported results for InMode, in USD.
- Market cap
- 777.4M
- Revenue (TTM)
- 374.6M
- P/E ratio
- 11.1
- EPS (diluted, TTM)
- 1.2
- Dividend yield
- —
- Profit margin
- 20.7%
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 370.5M | 85.4M | 93.8M | |
| 394.8M | 112.5M | 181.3M | |
| 492M | 195.7M | 197.9M | |
| 454.3M | 197.9M | 161.5M |